Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>Willis Towers Watson</dc:creator>
<dc:date>2024</dc:date>
<dc:description xml:lang="es">Sumario: The life science sector has experienced rapid evolution in recent years, driven by scientific breakthroughs in areas such as gene and cell therapies, biologics and new vaccines. However, this swift progress has also brought challenges. Some innovations have not lived up to their initial promise, and concerns about the high costs of drug development have grown. Additionally, companies are struggling to find individuals with the specialized skills they need. In our second Life Science global survey, we asked 400 senior decision-makers about their perspectives on this changing landscape. We explored their views on the main risks and opportunities, how they are managing emerging challenges, and their plans for the future</dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/185873.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>Willis Towers Watson</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Ciencias de la salud</dc:subject>
<dc:subject xml:lang="es">Gerencia de riesgos</dc:subject>
<dc:subject xml:lang="es">Riesgos emergentes</dc:subject>
<dc:subject xml:lang="es">Transformación digital</dc:subject>
<dc:subject xml:lang="es">Innovación empresarial</dc:subject>
<dc:subject xml:lang="es">Tendencias</dc:subject>
<dc:subject xml:lang="es">Factores de riesgo</dc:subject>
<dc:subject xml:lang="es">Encuestas</dc:subject>
<dc:type xml:lang="es">Libros</dc:type>
<dc:title xml:lang="es">Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges</dc:title>
<dc:format xml:lang="es">24 p.</dc:format>
<dc:relation xml:lang="es">Documento relacionado: Global life sciences risk outlook 2023. Managing emerging risks, challenges and opportunities in the life science sector : WTW global life science survey. - London : Willis Towers Watson, 2022</dc:relation>
<dc:coverage xml:lang="es">Ámbito geográfico: Internacional</dc:coverage>
</rdf:Description>
</rdf:RDF>